dimethylformamide has been researched along with Leukemia, Lymphocytic in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Breitman, TR; Imaizumi, M | 1 |
1 other study(ies) available for dimethylformamide and Leukemia, Lymphocytic
Article | Year |
---|---|
A combination of a T cell-derived lymphokine differentiation-inducing activity and a physiologic concentration of retinoic acid induces HL-60 to differentiate to cells with functional chemotactic peptide receptors.
Topics: Cell Adhesion; Cell Differentiation; Cell Line; Chemotaxis; Cytochalasin B; Dimethylformamide; Humans; Kinetics; Leukemia, Lymphoid; Lymphokines; N-Formylmethionine Leucyl-Phenylalanine; Phagocytes; Receptors, Formyl Peptide; Receptors, Immunologic; Superoxides; Tetradecanoylphorbol Acetate; Tretinoin | 1986 |